Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology|January 1, 1992
Lipoteichoic acid: a new inducer of nitric oxide synthaseM O Lonchampt, M Auguet, S Delaflotte, et al.Biomedica Biochimica Acta|January 1, 1984
Endothelium-dependent relaxations of rabbit isolated aorta produced by carbachol and by Ginkgo biloba extractS Delaflotte, M Auguet, F V DeFeudis, et al.FEBS Letters|February 3, 1992
Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cellsM Auguet, M O Lonchampt, S Delaflotte, et al.Pharmacological Research Communications|August 1, 1986
The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021J Baranes, A Hellegouarch, M Le Hegarat, et al.Neuroreport|May 19, 2000
BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal culturesJ G Marin, S Cornet, B Spinnewyn, et al.Pharmacological Research Communications|September 1, 1988
Antihypertensive profile of cicletanine, a furopyridine derivative: comparison with captopril, indapamide and prazosinE Malherbe, M Auguet, S Delaflotte, et al.Drugs Under Experimental and Clinical Research|January 1, 1988
In vivo and in vitro effects of cicletanine in spontaneously hypertensive ratsM Auguet, J M Guillon, S Delaflotte, et al.Drugs Under Experimental and Clinical Research|January 1, 1988
In vitro cardiovascular antihistamine properties of cicletanine in comparison with diphenhydramineM Auguet, S Delaflotte, A Hellegouarch, et al.Journal of Cardiovascular Pharmacology|January 1, 1989
Vascular mechanism of action of endothelin-1: effect of Ca2+ antagonistsP E Chabrier, M Auguet, P Roubert, et al.Plos One|August 9, 2018
Erectile dysfunction in obstructive sleep apnea patients: A randomized trial on the effects of Continuous Positive Airway Pressure (CPAP)Mercè Pascual, Jordi de Batlle, Ferran Barbé, et al.Pageof 6